- Avicanna (AVCN) has launched CBD derma-cosmetics brand Pura H&W in the U.S. with Red White & Bloom (RWB)
- Products include anti-aging serum, moisturizer, facial oil and clear skin gel
- They will be available through a proprietary e-commerce platform, third party e-commerce channels, big box retailers and Red White & Bloom’s U.S. retail infrastructure
- Red White & Bloom is a multi-state cannabis and hemp operator active in the U.S. and internationally
- Avicanna is a commercial-stage biopharmaceutical company focused on cannabinoid research, development and evidence-based products
- Red White & Bloom (RWB) is unchanged trading at $0.395 per share
- Avicanna (AVCN) is unchanged trading at $0.80 per share
Avicanna (AVCN) has launched CBD derma-cosmetics brand Pura H&W in the U.S. with Red White & Bloom (RWB).
Products include anti-aging serum, moisturizer, facial oil and clear skin gel, among others.
They will be available through a proprietary e-commerce platform, third-party e-commerce channels, big-box retailers and Red White & Bloom’s U.S. retail infrastructure.
Prior to release, Avicanna completed three clinical studies targeting cosmetic factors associated with aging, acne-prone skin and eczema-prone skin. They involved 156 patients and achieved positive results in the endpoints with no adverse effects.
“This marks the first major market for the brand where the products will be accessible to consumers over the counter and nationwide,” stated Aras Azadian, CEO of Avicanna. “We are optimistic about the launch of Pura in the United States, where we believe the clinically-backed and functional products will be highly differentiated and well-supported by our strategic partners Red White and Bloom and their U.S. commercial infrastructure.”
“We are excited to launch the Pura brand in the U.S. As the first clinically tested line in CBD cosmetics, the reaction from our stores and retail partners has been exciting and this is strategically aligned with our goal to be the most recognized and responsible multi-state operator in the market,” added Brad Rogers, CEO of Red White & Bloom. “We look forward to scaling the launch quickly in both our physical and digital channels.”
Red White & Bloom Brands is a multi-state cannabis and hemp operator active in the U.S. and internationally.
Avicanna is a commercial-stage biopharmaceutical company focused on cannabinoid research, development and evidence-based products.
Red White & Bloom (RWB) is unchanged trading at $0.395 per share as of 9:31 am EST.
Avicanna (AVCN) is unchanged trading at $0.80 per share as of 9:30 am EST.
